$1.69
0.063.68%
Last update: Nov 6, 7:46 PM
Tenax Therapeutics Inc
TENXNASDAQ
Tenax Therapeutics (TENX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.37 | $-0.40 | $-0.75 |
| Actual | $-0.31 | $-0.35 | $-0.35 | $-0.38 |
| Surprise | +13.9% | +5.41% | +12.5% | +49.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.39 | $-0.37 | $-0.37 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.31 | $-0.36 | 13.9 % |
| Q2 | Jul 31, 2026 | $-0.35 | $-0.37 | 5.41 % |
| Q1 | May 12, 2026 | $-0.35 | $-0.40 | 12.5 % |
| Q4 | Mar 10, 2026 | $-0.38 | $-0.75 | 49.3 % |
